UNSPSC 51294901: Tianeptine

This classification denotes a tricyclic antidepressive agent, analgesic, and thiazepine with the molecular formula C21H25ClN2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0T493YFU8O, chemically known as 7-((3-chloro-6,11-dihydro-6-methyldibenzo(c,f)(1,2)thiazepin-11-yl)amino)heptanoic acid s,s-dioxide but generally known as tianeptine, which bears US NIH Compound Identifier 68870. European Medicines Agency schedules Tianeptine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11007MIG.

UNSPSC 51294901 Tianeptine, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The three opportunities posted since April 2026 involve naloxone distribution systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—none of which focus on tianeptine, an atypical antidepressant with limited regulatory approval in the United States. State and local health agencies, cooperative purchasing alliances, and county health departments are the issuing bodies active under this code tag, but the work being solicited consists of emergency pharmaceutical supplies, pharmacy benefit program restructuring, and broad-based generic drug procurement rather than tianeptine products or services.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026, through the county's e-Procurement Portal. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, requesting vendor capabilities for a direct-to-manufacturer prescription program without a traditional competitive deadline. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026, for generic pharmaceuticals and OTC products with a proposal due date of March 26, 2026, supporting state and local facilities across Minnesota and Oregon. The code's recent activity reflects emergency response and cost-containment initiatives in pharmacy procurement rather than tianeptine-specific demand.